Accendra Health (ACH) Receivables (2009 - 2026)

Accendra Health (ACH) has 18 years of Receivables data on file, last reported at $103.7 million in Q1 2026.

• On a quarterly basis, Receivables fell 82.13% year-over-year to $103.7 million in Q1 2026; TTM through Mar 2026 was $103.7 million, a 82.13% decrease from a year earlier, with the FY2025 full-year figure at $95.9 million, down 56.06% from the prior year.
• Receivables for Q1 2026 stood at $103.7 million, up from $95.9 million in the prior quarter.
• Over the last five years, Receivables for ACH reached as high as $775.8 million in Q1 2022 and fell as low as $95.9 million in Q4 2025.
• Historically, Receivables has averaged $537.5 million across 5 years, with a median of $662.4 million in 2024.
• Across the five-year window, Receivables rose 12.02% in 2022 and slumped 82.13% in 2026, its largest moves.
• Year by year, Receivables stood at $763.5 million in 2022, then fell by 21.64% to $598.3 million in 2023, then plunged by 63.52% to $218.3 million in 2024, then plunged by 56.06% to $95.9 million in 2025, then climbed by 8.13% to $103.7 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $103.7 million in Q1 2026, $95.9 million in Q4 2025, and $202.7 million in Q3 2025.